Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOSIS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6%   Bankruptcy risk   6.6% 4.4% 3.6% 4.2% 3.2% 5.2% 8.3% 7.9%   Credit score (0-100)   37 47 51 48 55 42 29 31   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,368 4,456 3,921 5,229 6,133 5,097 0.0 0.0   EBITDA   584 718 250 1,207 451 -444 0.0 0.0   EBIT   573 709 239 1,196 440 -453 0.0 0.0   Pre-tax profit (PTP)   567.4 697.3 230.7 1,153.0 388.3 -465.7 0.0 0.0   Net earnings   438.6 453.7 152.2 989.6 295.7 -465.7 0.0 0.0   Pre-tax profit without non-rec. items   567 697 231 1,153 388 -466 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   12.3 24.8 18.7 12.7 6.7 2.9 0.0 0.0   Shareholders equity total   579 912 944 1,694 1,750 1,034 759 759   Interest-bearing liabilities   60.0 0.0 0.0 13.5 170 228 0.0 0.0   Balance sheet total (assets)   946 2,358 2,406 2,166 2,725 1,508 759 759   Net Debt   -434 -1,608 -1,497 -1,015 -780 -645 -758 -758     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,368 4,456 3,921 5,229 6,133 5,097 0.0 0.0   Gross profit growth   0.0% 88.1% -12.0% 33.4% 17.3% -16.9% -100.0% 0.0%   Employees   0 0 0 0 0 9 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   946 2,358 2,406 2,166 2,725 1,508 759 759   Balance sheet change%   0.0% 149.3% 2.0% -10.0% 25.8% -44.6% -49.7% 0.0%   Added value   583.8 717.6 250.3 1,206.6 451.5 -444.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   27 -1 -22 -22 -22 -18 -3 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.2% 15.9% 6.1% 22.9% 7.2% -8.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   60.6% 43.0% 10.3% 53.6% 19.7% -21.0% 0.0% 0.0%   ROI %   89.7% 85.4% 24.8% 92.3% 26.5% -27.9% 0.0% 0.0%   ROE %   75.8% 60.9% 16.4% 75.0% 17.2% -33.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   61.2% 42.7% 39.3% 78.2% 64.2% 68.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -74.3% -224.1% -598.1% -84.1% -172.8% 145.3% 0.0% 0.0%   Gearing %   10.4% 0.0% 0.0% 0.8% 9.7% 22.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   19.0% 41.3% 0.0% 1,075.3% 101.4% 10.7% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   2.4 2.1 1.7 4.2 2.7 2.9 0.0 0.0   Current Ratio   2.4 1.7 1.7 4.2 2.7 2.9 0.0 0.0   Cash and cash equivalent   493.9 1,608.4 1,496.8 1,028.6 950.1 873.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   516.3 953.0 905.8 1,510.3 1,605.9 888.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 -49 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 -49 0 0   EBIT / employee   0 0 0 0 0 -50 0 0   Net earnings / employee   0 0 0 0 0 -52 0 0